Spotlight: The ‘new Thalidomide’ The PJ Pod podcast

Artwork

Science PJ Pod Pharmaceutical Journal

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

The PJ Pod « »
Spotlight: The ‘new thalidomide’

1+ y ago 9:12

Dela

MP3•Episod hem

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.

… continue reading

43 episoder

#Science #PJ Pod #Pharmaceutical Journal

Artwork

Spotlight: The ‘new thalidomide’

published 1+ y ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av The PJ Pod and Pharmaceutical Journal. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av The PJ Pod and Pharmaceutical Journal eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

In the UK, three babies are still being born each month after being exposed to sodium valproate. This is despite the risk of foetal valproate spectrum disorder being known about for many years. In the first of a series of shorter ‘Spotlight’ episodes, executive editor Nigel Praities speaks with senior data journalist, Julia Robinson, about her recent investigation into this issue and whether NHS England is on track to meet its target to reduce the use of the drug in people who can get pregnant by 50% by the end of 2023. Julia also gives an insight into new research that may suggest the risks from sodium valproate and other drugs used for epilepsy may have been underestimated. Click here to read the full investigation: https://pharmaceutical-journal.com/article/feature/why-is-the-uk-struggling-to-contain-its-sodium-valproate-problem This episode was produced by Geoff Marsh.

… continue reading

43 episoder

#Science #PJ Pod #Pharmaceutical Journal

Все серии

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen